208 related articles for article (PubMed ID: 28318344)
1. Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.
Steeples LR; Anand N; Moraji J; Jones NP
Ocul Immunol Inflamm; 2018; 26(7):997-1004. PubMed ID: 28318344
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
3. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.
Maca SM; Abela-Formanek C; Kiss CG; Sacu SG; Benesch T; Barisani-Asenbauer T
Clin Exp Ophthalmol; 2009 May; 37(4):389-96. PubMed ID: 19594566
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
Angunawela RI; Heatley CJ; Williamson TH; Spalton DJ; Graham EM; Antcliffe RJ; Stanford MR
Acta Ophthalmol Scand; 2005 Oct; 83(5):595-9. PubMed ID: 16187999
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
Sørensen TL; Haamann P; Villumsen J; Larsen M
Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560
[TBL] [Abstract][Full Text] [Related]
8. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Batioğlu F; Ozmert E; Parmak N; Celik S
Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Wu WC; Cheng KC; Wu HJ
Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991
[TBL] [Abstract][Full Text] [Related]
11. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.
Leder HA; Jabs DA; Galor A; Dunn JP; Thorne JE
Am J Ophthalmol; 2011 Sep; 152(3):441-448.e2. PubMed ID: 21652023
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.
Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S
Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038
[TBL] [Abstract][Full Text] [Related]
14. Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.
Munk MR; Ram R; Rademaker A; Liu D; Setlur V; Chau F; Schmidt-Erfurth U; Goldstein DA
Acta Ophthalmol; 2015 Nov; 93(7):e561-7. PubMed ID: 25708777
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema.
Chang AA; Li H; Broadhead GK; Luo K; Zhu M
J Ocul Pharmacol Ther; 2015 Nov; 31(9):563-9. PubMed ID: 26218262
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.
Hogewind BF; Zijlstra C; Klevering BJ; Hoyng CB
Eur J Ophthalmol; 2008; 18(3):429-34. PubMed ID: 18465727
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Choudhry S; Ghosh S
Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]